glp 1 compound pharmacy Compounded GLP-1 Treatment tier compounded peptide protocol for weight management — formulated at provider Compounded GLP-1 Medications | Fridays

It is always wise to consult with a healthcare professional if you have concerns or are taking other medications

Online research-grade peptides are not suitable for human use and lack the necessary purity and quality standards for safe administration

According to the STEP 1 trial published in the New England Journal of Medicine, patients taking semaglutide 2.4 mg (Wegovy) achieved approximately: 3% to 5% body weight loss by week 12 10% to 12% body weight loss by week 28 15% to 17% body weight loss by week 68 (maximum effect) These figures represent average outcomes in clinical trials

Importantly, its the supervision (medical review, monitoring, dosing, integration) that makes the difference

Mild side effects can include nausea or stomach upset, which are typically transient